Scarcity of gender specific donor hearts highlights the importance of mesenchymal stem cells (MSCs) as a therapeutic tool for heart repair. However, inefficient incorporation, retention, and activity of MSCs in cardiac tissue remain an obstacle. Since surges in follicular estradiol (E2; μmolar-range) trigger tissue remodeling (e.g. ovulation) and E2 exerts beneficial actions on the cardiovascular system, we hypothesized that E2 may promote/improve MSC-mediated cardiac repair processes. Using Wharton's jelly (WJ)-derived MSCs we assessed the effects of E2 on MSC proliferation, directed migration, and engraftment in murine heart slices (using xCELLigence real-time cell-impedance system, DNA quantification, and microscopy) and on MSC-induced a...
BackgroundRecently, we showed that exogenous treatment with estrogen (E2) rescues pre-existing advan...
Background—Estradiol (E2) modulates the kinetics of circulating endothelial progenitor cells (EPCs) ...
ObjectivesDrug-eluting stents releasing antimitotic drugs are frequently used in patients undergoing...
Scarcity of gender specific donor hearts highlights the importance of mesenchymal stem cells (MSCs) ...
Therapeutic use of mesenchymal stem cells (MSCs) for tissue repair has great potential. MSCs from mu...
BACKGROUND: Stem cell therapy is a promising treatment modality for injured cardiac tissue. A nov...
Compared to the age-matched men, the incidence of cardiovascular diseases is lower in premenopausal ...
ObjectiveVascular endothelial growth factor, a critical factor in angiogenesis, mediates stem cell p...
Compared to the age-matched men, the incidence of cardiovascular diseases is lower in premenopausal ...
Aims Female sex and sex hormones contribute to cardiac remodelling. 17b-estradiol (E2) is involved i...
Experimental studies showed that 17{beta}-estradiol (E2) and activated Estrogen Receptors (ER) prote...
ObjectivesThis study investigated the effects of 17β-estradiol (E2) on gene regulation in human card...
Development of cardiac fibrosis portends the transition and deterioration from hypertrophy to dilati...
Abstract—Female gender and estrogen-replacement therapy in postmenopausal women are associated with ...
International audienceERβ (oestrogen receptor β) activation has been shown to be cardioprotective, b...
BackgroundRecently, we showed that exogenous treatment with estrogen (E2) rescues pre-existing advan...
Background—Estradiol (E2) modulates the kinetics of circulating endothelial progenitor cells (EPCs) ...
ObjectivesDrug-eluting stents releasing antimitotic drugs are frequently used in patients undergoing...
Scarcity of gender specific donor hearts highlights the importance of mesenchymal stem cells (MSCs) ...
Therapeutic use of mesenchymal stem cells (MSCs) for tissue repair has great potential. MSCs from mu...
BACKGROUND: Stem cell therapy is a promising treatment modality for injured cardiac tissue. A nov...
Compared to the age-matched men, the incidence of cardiovascular diseases is lower in premenopausal ...
ObjectiveVascular endothelial growth factor, a critical factor in angiogenesis, mediates stem cell p...
Compared to the age-matched men, the incidence of cardiovascular diseases is lower in premenopausal ...
Aims Female sex and sex hormones contribute to cardiac remodelling. 17b-estradiol (E2) is involved i...
Experimental studies showed that 17{beta}-estradiol (E2) and activated Estrogen Receptors (ER) prote...
ObjectivesThis study investigated the effects of 17β-estradiol (E2) on gene regulation in human card...
Development of cardiac fibrosis portends the transition and deterioration from hypertrophy to dilati...
Abstract—Female gender and estrogen-replacement therapy in postmenopausal women are associated with ...
International audienceERβ (oestrogen receptor β) activation has been shown to be cardioprotective, b...
BackgroundRecently, we showed that exogenous treatment with estrogen (E2) rescues pre-existing advan...
Background—Estradiol (E2) modulates the kinetics of circulating endothelial progenitor cells (EPCs) ...
ObjectivesDrug-eluting stents releasing antimitotic drugs are frequently used in patients undergoing...